Alazmi W M, Fogel E L, Watkins J L, McHenry L, Tector J A, Fridell J, Mosler P, Sherman S, Lehman G A
Indiana University Medical Center, Indianapolis, Indiana 46202, USA.
Endoscopy. 2006 Jun;38(6):571-4. doi: 10.1055/s-2006-925027.
The development of anastomotic strictures is one of the most common complications of orthotopic liver transplantation (OLT) with choledochocholedochostomy anastomosis. Endoscopic therapy with balloon dilation and/or stent placement is an effective therapy. The aim of this study was to assess the recurrence rate of anastomotic strictures and the features that predict recurrence after previously successful endoscopic therapy.
We searched the endoscopic retrograde cholangiopancreatography (ERCP) database for all patients who had had an OLT who were undergoing ERCP. The study cohort consisted of post-OLT patients who had a recurrence of anastomotic stricture after initial resolution following a course of endoscopic therapy.
A total of 916 OLT operations were performed during the study period from June 1994 to November 2004. Out of this group, 143 patients (15.6 %) were diagnosed with anastomotic stricture and underwent a total of 423 ERCPs for endoscopic treatment. Twelve patients who are still undergoing endoscopic therapy were excluded from the analysis. The technical success rate was 96.6 %, and the endoscopic therapy was successful in 82 % of patients; 18 % had a recurrence of cholestasis and ERCP revealed a recurrence of the anastomotic stricture that required intervention. The mean time of follow-up after stent removal was 28 months (range 1 - 114 months). The study did not reveal any clinical or endoscopic parameters that could predict recurrence, though the presence of a biliary leak at initial ERCP and a longer time to initial presentation were factors that showed a trend toward an increased likelihood of recurrence.
Biliary strictures remain a common complication after OLT, and in nearly one in five patients these strictures recur after initially successful endoscopic therapy. There were no clinical or endoscopic parameters identified in this study that predicted recurrence. Further study is needed to determine what type of endoscopic therapy would minimize the risk of stricture recurrence.
吻合口狭窄的发生是原位肝移植(OLT)行胆总管-胆总管吻合术最常见的并发症之一。球囊扩张和/或支架置入的内镜治疗是一种有效的治疗方法。本研究的目的是评估吻合口狭窄的复发率以及预测先前成功内镜治疗后复发的特征。
我们在接受内镜逆行胰胆管造影(ERCP)的所有OLT患者的ERCP数据库中进行搜索。研究队列包括OLT术后患者,这些患者在内镜治疗疗程后最初狭窄缓解后又出现吻合口狭窄复发。
在1994年6月至2004年11月的研究期间共进行了916例OLT手术。在这组患者中,143例(15.6%)被诊断为吻合口狭窄,并总共接受了423次ERCP内镜治疗。12例仍在接受内镜治疗的患者被排除在分析之外。技术成功率为96.6%,内镜治疗在82%的患者中取得成功;18%的患者出现胆汁淤积复发,ERCP显示吻合口狭窄复发需要干预。支架取出后的平均随访时间为28个月(范围1 - 114个月)。该研究未发现任何可预测复发的临床或内镜参数,尽管初始ERCP时存在胆漏以及初始就诊时间较长是显示复发可能性增加趋势的因素。
胆管狭窄仍是OLT术后常见的并发症,近五分之一的患者在最初内镜治疗成功后这些狭窄会复发。本研究未发现可预测复发的临床或内镜参数。需要进一步研究以确定何种类型的内镜治疗可将狭窄复发风险降至最低。